Decrease in cholesterol levels during the immunotherapy of cancer with interleukin-2.

IL-2, in addition to its immunomodulating and antitumour properties, induces important systemic actions, including cardiovascular, neuroendocrine and metabolic effects. The present study was carried out to evaluate IL-2 effects on cholesterol metabolism. The study included 14 advanced cancer patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Lissoni, P., Brivio, F., Pittalis, S., Perego, M. S., Ardizzoia, A., Mauri, O., Barni, S., Crispino, S., Tancini, G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1991
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977488/
https://www.ncbi.nlm.nih.gov/pubmed/1931624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977488/
https://www.ncbi.nlm.nih.gov/pubmed/1931624

Ejemplares similares